Related references
Note: Only part of the references are listed.Selectins and selectin ligands in extravasation of cancer cells and organ selectivity of metastasis
Stephanie Gout et al.
CLINICAL & EXPERIMENTAL METASTASIS (2008)
The ligand occupancy of endothelial protein C receptor switches the protease-activated receptor 1-dependent signaling specificity of thrombin from a permeability-enhancing to a banier-protective response in endothelial cells
Jong-Sup Bae et al.
BLOOD (2007)
Tumor cell-associated tissue factor and circulating hemostatic factors cooperate to increase metastatic potential through natural killer cell-dependent and -independent mechanisms
Joseph S. Palumbo et al.
BLOOD (2007)
The host inflammatory response promotes liver metastasis by increasing tumor cell arrest and extravasation
Patrick Auguste et al.
AMERICAN JOURNAL OF PATHOLOGY (2007)
Tumor-selective gene expression in a hepatic metastasis model after locoregional delivery of a replication-competent retrovirus vector
Kei Hiraoka et al.
CLINICAL CANCER RESEARCH (2006)
Thrombin induces tumor growth, metastasis, and angiogenesis: Evidence for a thrombin-regulated dormant tumor phenotype
Mary Lynn Nierodzik et al.
CANCER CELL (2006)
Both Th1 and Th2 cells require P-selectin glycoprotein ligand-1 for optimal rolling on inflamed endothelium
PR Mangan et al.
AMERICAN JOURNAL OF PATHOLOGY (2005)
Differential metastasis inhibition by clinically relevant levels of heparins - Correlation with selectin inhibition, not antithrombotic activity
JL Stevenson et al.
CLINICAL CANCER RESEARCH (2005)
Overexpressing endothelial cell protein C receptor alters the hemostatic balance and protects mice from endotoxin
W Li et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2005)
Endothelial barrier protection by activated protein C through PAR1-dependent sphingosine 1-phosphate receptor-1 crossactivation
C Feistritzer et al.
BLOOD (2005)
Endothelial P-selectin as a target of heparin action in experimental melanoma lung metastasis
RJ Ludwig et al.
CANCER RESEARCH (2004)
Recombinant human activated protein C reduces human endotoxin-induced pulmonary inflammation via inhibition of neutrophil chemotaxis
JA Nick et al.
BLOOD (2004)
Essential role for neutrophil recruitment to the liver in concanavalin A-induced hepatitis
CS Bonder et al.
JOURNAL OF IMMUNOLOGY (2004)
Endothelial barrier disruption by VEGF-mediated Src activity potentiates tumor cell extravasation and metastasis
S Weis et al.
JOURNAL OF CELL BIOLOGY (2004)
Recombinant murine-activated protein C is neuroprotective in a murine ischemic stroke model
JA Fernández et al.
BLOOD CELLS MOLECULES AND DISEASES (2003)
Activated protein C blocks p53-mediated apoptosis in ischemic human brain endothelium and is neuroprotective
T Cheng et al.
NATURE MEDICINE (2003)
Pharmacokinetic-pharmacodynamic analysis of drotrecogin alfa (activated) in patients with severe sepsis
WL Macias et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2002)
Realtime visualization of tumor cell/endothelial cell interactions during transmigration across the endothelial barrier
C Heyder et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2002)
In vivo evaluation of the early events associated with liver metastasis of circulating cancer cells
L Ding et al.
BRITISH JOURNAL OF CANCER (2001)
Gene expression profile of antithrombotic protein C defines new mechanisms modulating inflammation and apoptosis
DE Joyce et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Efficacy and safety of recombinant human activated protein C for severe sepsis.
GR Bernard et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Share Paper
